Satipharm Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Satipharm General Information

Description

Manufacturer and retailer of cannabinoid-based supplements headquartered in Dublin, Ireland. The company's food supplements are manufactured with a focus on the cannabidiol (CBD) by application of a patented CO2-based extraction procedure in the research laboratory and strict recording of quality assurance and quality control.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 6th Floor, 2 Grand Canal Square
  • Dublin D02 A342
  • Ireland
Primary Industry
Pharmaceuticals
Other Industries
Specialty Retail
Other Consumer Non-Durables
Acquirer
Vertical(s)
Corporate Office
  • 6th Floor, 2 Grand Canal Square
  • Dublin D02 A342
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Satipharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Satipharm‘s full profile, request access.

Request a free trial

Satipharm Patents

Satipharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017216928-A1 Oral solid cannabinoid formulations, methods for producing and using thereof Active 11-Feb-2016
AU-2017216928-B2 Oral solid cannabinoid formulations, methods for producing and using thereof Active 11-Feb-2016
CA-2981772-A1 Oral solid cannabinoid formulations, methods for producing and using thereof Active 11-Feb-2016
CA-2981772-C Oral solid cannabinoid formulations, methods for producing and using thereof Active 11-Feb-2016
EP-3253375-A1 Oral solid cannabinoid formulations, methods for producing and using thereof Active 11-Feb-2016 A61K9/1658
To view Satipharm’s complete patent history, request access »

Satipharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Satipharm Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Satipharm‘s full profile, request access.

Request a free trial

Satipharm FAQs

  • When was Satipharm founded?

    Satipharm was founded in 2015.

  • Where is Satipharm headquartered?

    Satipharm is headquartered in Dublin, Ireland.

  • What is the size of Satipharm?

    Satipharm has 2 total employees.

  • What industry is Satipharm in?

    Satipharm’s primary industry is Pharmaceuticals.

  • Is Satipharm a private or public company?

    Satipharm is a Private company.

  • What is the current valuation of Satipharm?

    The current valuation of Satipharm is .

  • What is Satipharm’s current revenue?

    The current revenue for Satipharm is .

  • Who are Satipharm’s investors?

    Delivra Health Brands and MMJ Bioscience have invested in Satipharm.

  • When was Satipharm acquired?

    Satipharm was acquired on 10-Mar-2021.

  • Who acquired Satipharm?

    Satipharm was acquired by Cann Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process